From Harvard’s Springer Gets $51.5M From Pharmas, Others, For Latest Startup:

Tim Springer

Tim Springer—

Tim Springer is an immunologist at Harvard University and the scientific founder of Morphic Therapeutics.

Underwriters and Partners

Xconomy Insight

Sponsored · Video
The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace

Sponsored · Webinar
Aug. 19 – Next-Generation Drug Discovery: Leveraging E3 Ligases for Targeted Protein Degradation
This new paradigm may well define a next dimension of precision medicine
Eurofins Discovery

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Xconomy on Demand

We offer a number of ways to subscribe for free!